Grant and accelerator · Asia-Pacific
Incu-Bio
Hong Kong Science and Technology Parks Corporation
Four-year programme with up to HK$6 million total support: up to HK$4 million financial subsidy and up to HK$2 million upfront support for regulatory activities such as clinical trials, plus laboratory infrastructure and business support.
Eligibility
Life/health-tech venture with R&D and commercialisation plan meeting HKSTP admission criteria; must support a four-year milestone plan and Hong Kong establishment/presence requirements.
What EBG would check
Publish with the official application link and re-check material terms on the scheduled refresh date.
Risks and conditions
The HK$2 million component is tied to approved regulatory/clinical work and is not unrestricted cash.
Sources
This entry was checked against the provider’s own page. East Bridge Global does not run this programme, is not paid to list it and cannot influence a decision on your application. Terms and closing dates move without notice, so confirm them on the provider’s page before you commit time to it.
Same group